Primary Record
Pacritinib
- In stock
- 9,571 g
- Purity
- 99.3 %
- CAS
- 937272-79-2
Compound Identifiers & Properties
- CAS
- 937272-79-2
- PubChem CID
- 46216796
- SMILES
- C1CCN(C1)CCOC2=C3COC/C=C/COCC4=CC(=CC=C4)C5=NC(=NC=C5)NC(=C3)C=C2
- Canonical SMILES
- C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1
Names & Synonyms
- Pacritinib
- Pacritinib (SB1518)
- pacritinibum
- 937272-79-2
- Vonjo
- SB1518
- PEDttHD
- Pacritinib [INN]
- Pacritinib(SB1518)
- Vonjo (TN)
- Pacritinib (Standard)
- SB-1518
- SB1518(Pacritinib)
- RefChem:58092
- Pacritinib (USAN/INN)
- Pacritinib [USAN:INN]
- G22N65IL3O
- PACRITINIB [USAN]
- ONX-0803
- PACRITINIB [WHO-DD]
- SB-1518 TFA salt
- UNII-G22N65IL3O
- MFCD22572772
- SB 1518
- C28H32N4O3
- DTXSID801045679
- GTPL7793
- orb1301145
- CHEMBL2035187
- CHEMBL2181330
- Oral JAK2 Inhibitor SB1518
- SCHEMBL22819303
- SCHEMBL29358663
- SCHEMBL29617552
- EX-A240
- CHEBI:231350
- DTXCID201527601
- GLXC-90080
- AMY23364
- AOB87797
- BAX 2201
- BCP09091
- MMB27279
- ONX 0803
- 2626AH
- ABP001102
- ARD193602
- BDBM50210177
- BDBM50400312
- HY-16379R
- NSC759674
- NSC781626
- s8057
- AKOS037515687
- ACN-025761
- CCG-269464
- CS-1741
- DB11697
- NSC-759674
- NSC-781626
- NCGC00381564-02
- NCGC00381564-08
- NCGC00381564-09
- NCGC00390623-02
- AC-30280
- AS-35036
- HY-16379
- FT-0701734
- SW219864-1
- J3.548.848K
- A12694
- D11768
- SB1518;SB-1518;SB 1518
- Z-3133
- A856343
- (16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-Dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene
- 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
- Q3888693
- BRD-K19034817-001-01-4
- BRD-K19034817-001-02-2
- BRD-K19034817-001-04-8
- B0084-462754
- (16E)-11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(24),2(27),3,5,8(26),9,11,16,21(25),22-decaene
- 14,19-Dioxa-5,7,27-triazatetracyclo(19.3.1.12,6.18,12)heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene, 11-(2-(1-pyrrolidinyl)ethoxy)-, (16E)-
- (16E)-11-(2-(pyrrolidin-1-yl)ethoxy)-14,19-dioxa-5,7,27-triazatetracyclo(19.3.1.1^(2,6).1^(8,12))heptacosa-1(25),2(27),3,5,8,10,12(26),16,21,23-decaene
- (16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2(27),3,5,8(26),9,11,16,21,23-decaene
- (16E)-11-[2-(pyrrolidin-1-yl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(27),3,5,8(26),9,11,16,21,23-decaene
- 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
- 11-[2-(pyrrolidin-1-yl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(24),2(27),3,5,8,10,12(26),16,21(25),22-decaene
- 11-[2-(Pyrrolidine-1-yl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosane-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene
- 2197126-32-0
- 6T3
- SB 1518; (E)-44-(2-(pyrrolidin-1-yl)ethoxy)-6,11-dioxa-3-aza-2(4,2)-pyrimidina-1,4(1,3)-dibenzenacyclododecaphan-8-ene
- SB-1518|||(16E)-11-[2-(1-Pyrrolidinyl)ethoxy]-14,19-dioxa-5,7,27-triazatetracyclo[19.3.1.12,6.18,12]heptacosa-1(25),2,4,6(27),8,10,12(26),16,21,23-decaene